StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Ironwood Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2020 was 99.2%. For fiscal 2020 it was 99.2%, against 94.4% the year before. The highest annual figure on record is 100.0% in fiscal 2015.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 202099.2%+4.8
FY2019Dec 31, 201994.4%+3.9
FY2018Dec 31, 201890.6%−3.0
FY2017Dec 31, 201793.6%−5.7
FY2016Dec 31, 201699.3%−0.7
FY2015Dec 31, 2015100.0%+6.9
FY2014Dec 31, 201493.1%+24.6
FY2013Dec 31, 201368.5%−30.8
FY2012Dec 31, 201299.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2020Dec 31, 202099.2%+8.0
Q3 FY2020Sep 30, 2020100.0%+0.4
Q2 FY2020Jun 30, 2020100.0%+11.1
Q1 FY2020Mar 31, 202097.2%−1.3
Q4 FY2019Dec 31, 201991.3%+7.7
Q3 FY2019Sep 30, 201999.6%+6.6
Q2 FY2019Jun 30, 201988.9%−6.1
Q1 FY2019Mar 31, 201998.5%+2.3
Q4 FY2018Dec 31, 201883.6%−6.9
Q3 FY2018Sep 30, 201893.0%−0.0
Q2 FY2018Jun 30, 201895.0%+0.4
Q1 FY2018Mar 31, 201896.2%−2.8
Q4 FY2017Dec 31, 201790.5%–
Q3 FY2017Sep 30, 201793.0%–
Q2 FY2017Jun 30, 201794.6%–
Q1 FY2017Mar 31, 201799.0%–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?